Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

MeSH term MeSH ID Detail
Niemann-Pick Disease, Type C D052556 1 associated lipids
Farber Lipogranulomatosis D055577 1 associated lipids
Tachycardia, Sinus D013616 2 associated lipids
Sensation Disorders D012678 2 associated lipids
Ileus D045823 3 associated lipids
Fabry Disease D000795 4 associated lipids
Hematologic Neoplasms D019337 4 associated lipids
Shock, Hemorrhagic D012771 4 associated lipids
Adenomatous Polyps D018256 4 associated lipids
Ovarian Diseases D010049 5 associated lipids
Dilatation, Pathologic D004108 5 associated lipids
Pregnancy, Ectopic D011271 5 associated lipids
Anemia, Aplastic D000741 6 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Teratocarcinoma D018243 7 associated lipids
Rhabdomyosarcoma D012208 7 associated lipids
Eye Abnormalities D005124 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Thrombocythemia, Essential D013920 9 associated lipids
Cardiomyopathies D009202 10 associated lipids
Retinal Detachment D012163 10 associated lipids
Influenza, Human D007251 11 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Arterial Occlusive Diseases D001157 12 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Lung Injury D055370 14 associated lipids
Thrombocytopenia D013921 15 associated lipids
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Vascular Diseases D014652 16 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Tuberculosis D014376 20 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Sarcoma 180 D012510 21 associated lipids
Anemia D000740 21 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Hypersensitivity D006967 22 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Pulmonary Edema D011654 23 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Fibrosis D005355 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Per page 10 20 50 100 | Total 101

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Pyne NJ et al. Sphingosine 1-phosphate signalling in cancer. 2012 Biochem. Soc. Trans. pmid:22260672
Yu FX et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. 2012 Cell pmid:22863277
Miller E et al. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. 2012 Chem. Biol. pmid:22884261
Majumdar I and Mastrandrea LD Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome. 2012 Endocrine pmid:22228496
Wang S et al. A polysaccharides MDG-1 augments survival in the ischemic heart by inducing S1P release and S1P1 expression. 2012 Int. J. Biol. Macromol. pmid:22197795
Armstrong SM et al. Co-regulation of transcellular and paracellular leak across microvascular endothelium by dynamin and Rac. 2012 Am. J. Pathol. pmid:22203054
Bode C and Gräler MH Immune regulation by sphingosine 1-phosphate and its receptors. 2012 Arch. Immunol. Ther. Exp. (Warsz.) pmid:22159476
Cyster JG and Schwab SR Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. 2012 Annu. Rev. Immunol. pmid:22149932
Kurata H et al. Structure-activity relationship studies of S1P agonists with a dihydronaphthalene scaffold. 2012 Bioorg. Med. Chem. Lett. pmid:22153936
Calise S et al. Sphingosine 1-phosphate stimulates proliferation and migration of satellite cells: role of S1P receptors. 2012 Biochim. Biophys. Acta pmid:22178384
Balczerski B et al. Analysis of sphingosine-1-phosphate signaling mutants reveals endodermal requirements for the growth but not dorsoventral patterning of jaw skeletal precursors. 2012 Dev. Biol. pmid:22185793
Witt W et al. Sphingosine-1-phosphate induces contraction of valvular interstitial cells from porcine aortic valves. 2012 Cardiovasc. Res. pmid:22232739
Madhunapantula SV et al. Targeting sphingosine kinase-1 to inhibit melanoma. 2012 Pigment Cell Melanoma Res pmid:22236408
Che W et al. Sphingosine 1-phosphate induces MKP-1 expression via p38 MAPK- and CREB-mediated pathways in airway smooth muscle cells. 2012 Biochim. Biophys. Acta pmid:22743041
Testai FD et al. Changes in the cerebrospinal fluid ceramide profile after subarachnoid hemorrhage. 2012 Stroke pmid:22713492
García-Merino JA and Sánchez AJ [Basic mechanisms of action of fingolimod in relation to multiple sclerosis]. 2012 Rev Neurol pmid:22718407
Shmyrev VI et al. [Sphingosine-1-phosphate signaling system and the innovative mechanism of action of fingolimod in treatment of multiple sclerosis: review of foreign literature]. 2012 Zh Nevrol Psikhiatr Im S S Korsakova pmid:22677684
Upadhyaya P et al. The sphingolipid degradation product trans-2-hexadecenal forms adducts with DNA. 2012 Biochem. Biophys. Res. Commun. pmid:22727907
Duru EA et al. Role of S-1-P receptors and human vascular smooth muscle cell migration in diabetes and metabolic syndrome. 2012 J. Surg. Res. pmid:22480845
Moberly JB et al. Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: results from a 12-week, open-label pilot study in multiple sclerosis patients. 2012 J. Neuroimmunol. pmid:22465063
Li Q et al. The reduction of allograft arteriosclerosis in intestinal transplant is associated with sphingosine kinase 1/sphingosine-1-phosphate signaling after fish oil treatment. 2012 Transplantation pmid:22466786
von Bismarck P et al. IKK NBD peptide inhibits LPS induced pulmonary inflammation and alters sphingolipid metabolism in a murine model. 2012 Pulm Pharmacol Ther pmid:22469869
El-Shewy HM et al. Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells. 2012 Mol. Endocrinol. pmid:22422617
Eisenhoffer GT et al. Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia. 2012 Nature pmid:22504183
Peng P et al. [Effect of sphingosine-1-phosphate on chemotherapy-induced ovarian damage and on the efficacy of chemotherapy in mice bearing S180 tumor]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:22445989
Podbielska M et al. Signaling and regulatory functions of bioactive sphingolipids as therapeutic targets in multiple sclerosis. 2012 Neurochem. Res. pmid:22451227
Lucki NC et al. Sphingosine-1-phosphate rapidly increases cortisol biosynthesis and the expression of genes involved in cholesterol uptake and transport in H295R adrenocortical cells. 2012 Mol. Cell. Endocrinol. pmid:21864647
Altay O et al. Isoflurane delays the development of early brain injury after subarachnoid hemorrhage through sphingosine-related pathway activation in mice. 2012 Crit. Care Med. pmid:22488000
Tian YL et al. [Research progress of the selective sphingosine-1-phosphate receptor 1 agonists]. 2012 Yao Xue Xue Bao pmid:22493799
Makino Y et al. Role of sphingosine-1-phosphate inβ-adrenoceptor desensitization via Ca(2+) sensitization in airway smooth muscle. 2012 Allergol Int pmid:22441633
Shi Y et al. Sphingosine kinase-2 inhibition improves mitochondrial function and survival after hepatic ischemia-reperfusion. 2012 J. Hepatol. pmid:21756852
Kim CH et al. Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors. 2012 Leukemia pmid:21769103
Obinata H and Hla T Sphingosine 1-phosphate in coagulation and inflammation. 2012 Semin Immunopathol pmid:21805322
Beech DJ Integration of transient receptor potential canonical channels with lipids. 2012 Acta Physiol (Oxf) pmid:21624095
Antoon JW and Beckman BS Anti-proliferative effects of the novel ceramide analog (S)-2-(benzylideneamino)-3-hydroxy-N-tetrade-cylpropanamide in chemoresistant cancer. 2012 Bioorg. Med. Chem. Lett. pmid:22366655
Kipp M and Amor S FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination. 2012 Mult. Scler. pmid:22383435
Fujii Y et al. Blocking S1P interaction with S1P₁ receptor by a novel competitive S1P₁-selective antagonist inhibits angiogenesis. 2012 Biochem. Biophys. Res. Commun. pmid:22387544
Cantrell Stanford J et al. Sphingosine 1-phosphate (S1P) regulates glucose-stimulated insulin secretion in pancreatic beta cells. 2012 J. Biol. Chem. pmid:22389505
Liu W et al. S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition. 2012 Exp. Cell Res. pmid:22406263
Fukuhara S et al. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. 2012 J. Clin. Invest. pmid:22406534
Yang F et al. Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis. 2012 Cancer Biol. Ther. pmid:22406995
Kwak HI et al. Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation. 2012 Angiogenesis pmid:22407449
Singh AT et al. Sphingosine-sphingosine-1-phosphate pathway regulates trophoblast differentiation and syncytialization. 2012 Reprod. Biomed. Online pmid:22197131
Pitman MR et al. Molecular targets of FTY720 (fingolimod). 2012 Curr. Mol. Med. pmid:22834825
Karmouty-Quintana H et al. Treatment with a sphingosine-1-phosphate analog inhibits airway remodeling following repeated allergen exposure. 2012 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:22287614
Curry FE et al. Erythrocyte-derived sphingosine-1-phosphate stabilizes basal hydraulic conductivity and solute permeability in rat microvessels. 2012 Am. J. Physiol. Heart Circ. Physiol. pmid:22865384
Masuko K et al. Sphingosine-1-phosphate modulates expression of vascular endothelial growth factor in human articular chondrocytes: a possible new role in arthritis. 2012 Int J Rheum Dis pmid:22898216
Schmitz EI et al. Sphingosine 1-phosphate protects primary human keratinocytes from apoptosis via nitric oxide formation through the receptor subtype S1P₃. 2012 Mol. Cell. Biochem. pmid:22899173
Bassoy EY and Baran Y Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells. 2012 Biomed. Pharmacother. pmid:22326625
Törnquist K Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells. 2012 Acta Physiol (Oxf) pmid:21338471
Adamson RH et al. Attenuation by sphingosine-1-phosphate of rat microvessel acute permeability response to bradykinin is rapidly reversible. 2012 Am. J. Physiol. Heart Circ. Physiol. pmid:22427519
Babahosseini H et al. Roles of bioactive sphingolipid metabolites in ovarian cancer cell biomechanics. 2012 Conf Proc IEEE Eng Med Biol Soc pmid:23366417
Korbelik M et al. Monitoring ceramide and sphingosine-1-phosphate levels in cancer cells and macrophages from tumours treated by photodynamic therapy. 2012 Photochem. Photobiol. Sci. pmid:22354109
Cuvillier O [Sphingosine 1-phosphate receptors: from biology to physiopathology]. 2012 Med Sci (Paris) pmid:23171898
Patel SA et al. Overexpression of the adiponectin receptor AdipoR1 in rat skeletal muscle amplifies local insulin sensitivity. 2012 Endocrinology pmid:22989629
Fernández-Pisonero I et al. Lipopolysaccharide and sphingosine-1-phosphate cooperate to induce inflammatory molecules and leukocyte adhesion in endothelial cells. 2012 J. Immunol. pmid:23089395
Ma Y et al. Sphingosine-1-phosphate (S1P) mediates darkness-induced stomatal closure through raising cytosol pH and hydrogen peroxide (Hâ‚‚Oâ‚‚) levels in guard cells in Vicia faba. 2012 Sci China Life Sci pmid:23090064
Taniguchi M et al. Regulation of autophagy and its associated cell death by "sphingolipid rheostat": reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway. 2012 J. Biol. Chem. pmid:23035115
Kawashima T et al. Contrary effects of sphingosine-1-phosphate on expression of α-smooth muscle actin in transforming growth factor β1-stimulated lung fibroblasts. 2012 Eur. J. Pharmacol. pmid:23041148
Sorci-Thomas MG and Thomas MJ High density lipoprotein biogenesis, cholesterol efflux, and immune cell function. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:23077142
Meacci E et al. Sphingosine-1-phosphate signaling in skeletal muscle cells. 2012 Methods Mol. Biol. pmid:22528446
Wong RC et al. Maintenance of human embryonic stem cells by sphingosine-1-phosphate and platelet-derived growth factor. 2012 Methods Mol. Biol. pmid:22528447
Bieberich E Ceramide and sphingosine-1-phosphate signaling in embryonic stem cell differentiation. 2012 Methods Mol. Biol. pmid:22528448
Callihan P and Hooks SB Sphingosine-1-phosphate signaling in neural progenitors. 2012 Methods Mol. Biol. pmid:22528449
Su SC and Bayless KJ Utilizing sphingosine-1-phosphate to stimulate sprouting angiogenesis. 2012 Methods Mol. Biol. pmid:22528450
Lim M et al. The role of sphingosine kinase 1/sphingosine-1-phosphate pathway in the myogenic tone of posterior cerebral arteries. 2012 PLoS ONE pmid:22532844
Lynch KR Building a better sphingosine kinase-1 inhibitor. 2012 Biochem. J. pmid:22533672
Mann DL Sphingosine 1-phosphate as a therapeutic target in heart failure: more questions than answers. 2012 Circulation pmid:22534620
Meissner A et al. Tumor necrosis factor-α-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure. 2012 Circulation pmid:22534621
Callihan P et al. Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells. 2012 Neuropharmacology pmid:22016110
Maceyka M et al. Sphingosine-1-phosphate signaling and its role in disease. 2012 Trends Cell Biol. pmid:22001186
Knapp M et al. Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat. 2012 Basic Res. Cardiol. pmid:22961594
Gupta VK et al. Focus on molecules: Sphingosine 1 Phosphate (S1P). 2012 Exp. Eye Res. pmid:22001715
Shea BS and Tager AM Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis. 2012 Proc Am Thorac Soc pmid:22802282
Nakahara K et al. The Sjögren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway. 2012 Mol. Cell pmid:22633490
Lim KG et al. Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival. 2012 Br. J. Pharmacol. pmid:22251058
Jiang H et al. Application of ultra-performance liquid chromatography coupled with mass spectrometry to metabonomic study on spontaneously hypertensive rats and intervention effects of Ping Gan prescription. 2012 J Sep Sci pmid:22282408
Takeshita H et al. Sphingosine 1-phosphate (S1P)/S1P receptor 1 signaling regulates receptor activator of NF-κB ligand (RANKL) expression in rheumatoid arthritis. 2012 Biochem. Biophys. Res. Commun. pmid:22326262
Shannon LA et al. CCR7/CCL19 controls expression of EDG-1 in T cells. 2012 J. Biol. Chem. pmid:22334704
Nunes J et al. Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection. 2012 Br. J. Cancer pmid:22315056
Shimizu T et al. Sphingosine-1-phosphate receptor 3 promotes neointimal hyperplasia in mouse iliac-femoral arteries. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:22308044
Canals D et al. Protein phosphatase 1α mediates ceramide-induced ERM protein dephosphorylation: a novel mechanism independent of phosphatidylinositol 4, 5-biphosphate (PIP2) and myosin/ERM phosphatase. 2012 J. Biol. Chem. pmid:22311981
Knapp M et al. Decreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failure. 2012 Adv Med Sci pmid:22296975
Nagahashi M et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. 2012 Cancer Res. pmid:22298596
Ratajczak J et al. A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate gradient. 2012 Leukemia pmid:22343521
Mascall KS et al. Sphingosine-1-phosphate-induced release of TIMP-2 from vascular smooth muscle cells inhibits angiogenesis. 2012 J. Cell. Sci. pmid:22344262
Hsu A et al. Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells. 2012 Int. J. Oncol. pmid:22344462
Tse KW et al. Small molecule inhibitors of the Pyk2 and FAK kinases modulate chemoattractant-induced migration, adhesion and Akt activation in follicular and marginal zone B cells. 2012 Jan-Feb Cell. Immunol. pmid:22507871
Fournie P et al. Sphingosine-1 phosphate prevents ethanol-induced corneal epithelial apoptosis. 2012 Mar-Apr Indian J Ophthalmol pmid:22446906
Iwaki S et al. Posttranscriptional regulation of expression of plasminogen activator inhibitor type-1 by sphingosine 1-phosphate in HepG2 liver cells. 2012 Nov-Dec Biochim. Biophys. Acta pmid:22819712
Takuwa Y et al. Sphingosine-1-phosphate signaling in physiology and diseases. 2012 Sep-Oct Biofactors pmid:22674845
Price MM et al. A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma. 2013 J. Allergy Clin. Immunol. pmid:22939756
Wirotanseng LN et al. Gq rather than G11 preferentially mediates nociceptor sensitization. 2013 Mol Pain pmid:24156378
Ishii M and Kikuta J Sphingosine-1-phosphate signaling controlling osteoclasts and bone homeostasis. 2013 Biochim. Biophys. Acta pmid:22691949
Hardin C et al. Glassy dynamics, cell mechanics, and endothelial permeability. 2013 J Phys Chem B pmid:23638866
Egom EE et al. HDL quality or cholesterol cargo: what really matters--spotlight on sphingosine-1-phosphate-rich HDL. 2013 Curr. Opin. Lipidol. pmid:23652570
Lundblad C et al. Treatment with the sphingosine-1-phosphate analogue FTY 720 reduces loss of plasma volume during experimental sepsis in the rat. 2013 Acta Anaesthesiol Scand pmid:23683126
Bernhart E et al. Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro. 2013 Exp. Cell Res. pmid:23562655
Weichand B et al. Apoptotic cells enhance sphingosine-1-phosphate receptor 1 dependent macrophage migration. 2013 Eur. J. Immunol. pmid:23934754
Morad SA et al. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells. 2013 Biochim. Biophys. Acta pmid:23939396